Overview

Taste Assessment of Ozanimod

Status:
Not yet recruiting

Trial end date:
2021-10-18

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the taste characteristics of ozanimod formulations, alone and mixed, in order to develop a pediatric oral form of ozanimod.

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb

Treatments:

Ozanimod